KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Preferred Dividend Payments: 2017-2021

Historic Preferred Dividend Payments for Arbutus Biopharma (ABUS) over the last 5 years, with Dec 2021 value amounting to $12.1 million.

  • Arbutus Biopharma's Preferred Dividend Payments fell 81.62% to $574,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $12.1 million, marking a year-over-year increase of 0.13%. This contributed to the annual value of $12.1 million for FY2021, which is 0.13% up from last year.
  • Arbutus Biopharma's Preferred Dividend Payments amounted to $12.1 million in FY2021, which was up 0.13% from $12.1 million recorded in FY2020.
  • Arbutus Biopharma's Preferred Dividend Payments' 5-year high stood at $12.1 million during FY2021, with a 5-year trough of $911,000 in FY2017.
  • Over the past 3 years, Arbutus Biopharma's median Preferred Dividend Payments value was $12.1 million (recorded in 2020), while the average stood at $11.8 million.
  • Data for Arbutus Biopharma's Preferred Dividend Payments shows a peak YoY soared of 1,007.68% (in 2018) over the last 5 years.
  • Over the past 5 years, Arbutus Biopharma's Preferred Dividend Payments (Yearly) stood at $911,000 in 2017, then soared by 1,007.68% to $10.1 million in 2018, then grew by 10.48% to $11.1 million in 2019, then rose by 8.74% to $12.1 million in 2020, then climbed by 0.13% to $12.1 million in 2021.